CPIG
Chicago Partners Investment Group Portfolio holdings
AUM
$3.47B
1-Year Return
16.46%
This Quarter Return
+8.85%
1 Year Return
+16.46%
3 Year Return
+59.01%
5 Year Return
+97.48%
10 Year Return
+126.98%
AUM
$3.47B
AUM Growth
+$462M
(+15%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
4.24%
Top 10 Holdings %
Top 10 Hldgs %
23.03%
Holding
1,122
New
189
Increased
576
Reduced
264
Closed
27
Top Buys
| 1 |
Vanguard Core Bond ETF
VCRB
|
$7.5M |
| 2 |
NVIDIA
NVDA
|
$5.46M |
| 3 |
Invesco S&P 500 Momentum ETF
SPMO
|
$5.3M |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
$4.89M |
| 5 |
iShares Gold Trust
IAU
|
$4.15M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
$4.32M |
| 2 |
Vanguard Total Bond Market
BND
|
$3.53M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$3.24M |
| 4 |
Innovator Equity Managed Floor ETF
SFLR
|
$3.01M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$2.41M |
Sector Composition
| 1 | Technology | 9.62% |
| 2 | Financials | 9.05% |
| 3 | Energy | 7.27% |
| 4 | Consumer Discretionary | 2.34% |
| 5 | Industrials | 2.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Rigetti Computing
RGTI
$4.89B
| $168K | ﹤0.01% |
10,378
+34
| +0.3% | +$549 |
|
1052
Iovance Biotherapeutics
IOVA
$901M
| $163K | ﹤0.01% |
40,989
+363
| +0.9% | +$1.44K |
|
1053
Lumen
LUMN
$4.87B
| $156K | ﹤0.01% |
34,121
-652
| -2% | -$2.98K |
|
1054
PG&E
PCG
$33.2B
| $152K | ﹤0.01% |
+11,080
| New | +$152K |
|
1055
Uranium Energy
UEC
$4.96B
| $150K | ﹤0.01% |
17,593
+339
| +2% | +$2.88K |
|
1056
Goldman Sachs BDC
GSBD
$1.31B
| $134K | ﹤0.01% |
11,302
| – | – |
|
|
GLV
1057
Clough Global Dividend & Income Fund
GLV
$72.2M
| $129K | ﹤0.01% |
22,924
| – | – |
|
1058
Viatris
VTRS
$12.2B
| $126K | ﹤0.01% |
13,479
+2,628
| +24% | +$24.6K |
|
1059
Park Hotels & Resorts
PK
$2.4B
| $125K | ﹤0.01% |
+11,009
| New | +$125K |
|
1060
Treace Medical Concepts
TMCI
$453M
| $125K | ﹤0.01% |
20,519
-238
| -1% | -$1.45K |
|
1061
RenovoRx
RNXT
$45.4M
| $117K | ﹤0.01% |
92,356
| – | – |
|
1062
Leggett & Platt
LEG
$1.35B
| $115K | ﹤0.01% |
+10,880
| New | +$115K |
|
1063
Nuveen Floating Rate Income Fund
JFR
$1.13B
| $114K | ﹤0.01% |
13,412
-4,764
| -26% | -$40.4K |
|
|
MFM
1064
MFS Municipal Income Trust
MFM
$213M
| $110K | ﹤0.01% |
21,725
-4,653
| -18% | -$23.5K |
|
1065
Wave Life Sciences
WVE
$1.32B
| $105K | ﹤0.01% |
12,265
-443
| -3% | -$3.79K |
|
1066
Prothena Corp
PRTA
$460M
| $99.8K | ﹤0.01% |
14,759
+247
| +2% | +$1.67K |
|
|
SABA
1067
Saba Capital Income & Opportunities Fund II
SABA
$257M
| $96.1K | ﹤0.01% |
10,355
-531
| -5% | -$4.93K |
|
|
GLO
1068
Clough Global Opportunities Fund
GLO
$240M
| $85.6K | ﹤0.01% |
15,742
-8
| -0.1% | -$44 |
|
1069
ImmunityBio
IBRX
$2.27B
| $79.5K | ﹤0.01% |
+26,583
| New | +$79.5K |
|
1070
Eos Energy Enterprises
EOSE
$2.01B
| $79.4K | ﹤0.01% |
+12,724
| New | +$79.4K |
|
1071
Cue Biopharma
CUE
$59.9M
| $78.6K | ﹤0.01% |
88,302
-2,000
| -2% | -$1.78K |
|
1072
scPharmaceuticals
SCPH
$299M
| $77.9K | ﹤0.01% |
14,498
+1,770
| +14% | +$9.51K |
|
1073
E.W. Scripps
SSP
$261M
| $70.8K | ﹤0.01% |
21,121
+4,730
| +29% | +$15.8K |
|
1074
Hanesbrands
HBI
$2.27B
| $70.3K | ﹤0.01% |
14,868
-669
| -4% | -$3.16K |
|
|
ACTU
1075
Actuate Therapeutics, Inc. Common stock
ACTU
$181M
| $68.4K | ﹤0.01% |
10,365
| – | – |
|